In this surgically managed RCC BM cohort, brain metastases from mRCC demonstrate nonrandom spatial distribution, with overrepresentation in posterior circulation and posterior cerebral artery territories.
Limited data on the timing of brain metastases development and subsequent prognosis by breast cancer subtype exist. We retrospectively evaluated a cohort of 671 patients diagnosed with brain metastases secondary to breast cancer. Patients were categorized by subtype: human epidermal growth factor receptor 2-positive (H...
N. S. Rashid, N. Lamba, I. Ricca et al.· JNCI Cancer Spectrum· 0 citations
There was so significant difference in number of patients receiving local brain treatment based on PDL1 and molecular genetic status that Prospective randomised clinical trials are needed to test the utility of upfront local intracranial treatments in this cohort.
Harriet Hebbes, Sara Walters, Patrick Forster et al.· Neuro-Oncology· 0 citations
Background Up to 50% of Brain metastases (BM) are associated with lung cancer. Different radiologic features such as tumor size, anatomical location and peritumoral edema affect the clinical course. However, their impact on prognosis and survival is controversial. Patients and Methods A retrospective study of lung canc...
Y. Laviv, O. Regev, Andrew A. Kanner et al.· The Neuroradiology Journal· 0 citations
Recurrent CNAs enriched in RCC brain metastases, including 4q loss, 7p gain, 7q gain, 8p loss, 8q gain, 9p21.3 deletion were associated with increased incidence of brain metastases across multiple primary cancer types in xenograft mouse models.
Betul Gok Yavuz, E. Hasanov· The Oncologist· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.